Repository logo
 

High turnover drives prolonged persistence of influenza in managed pig herds.

Published version
Peer-reviewed

Change log

Authors

Aguas, Ricardo 
Riley, Steven 
Loeffen, Willie LA 
Wood, James LN 

Abstract

Pigs have long been hypothesized to play a central role in the emergence of novel human influenza A virus (IAV) strains, by serving as mixing vessels for mammalian and avian variants. However, the key issue of viral persistence in swine populations at different scales is ill understood. We address this gap using epidemiological models calibrated against seroprevalence data from Dutch finishing pigs to estimate the 'critical herd size' (CHS) for IAV persistence. We then examine the viral phylogenetic evidence for persistence by comparing human and swine IAV. Models suggest a CHS of approximately 3000 pigs above which influenza was likely to persist, i.e. orders of magnitude lower than persistence thresholds for IAV and other acute viruses in humans. At national and regional scales, we found much stronger empirical signatures of prolonged persistence of IAV in swine compared with human populations. These striking levels of persistence in small populations are driven by the high recruitment rate of susceptible piglets, and have significant implications for management of swine and for overall patterns of genetic diversity of IAV.

Description

Keywords

influenza, mathematical modelling, surveillance, swine, transmission dynamics, Animals, Influenza A virus, Models, Biological, Orthomyxoviridae Infections, Swine, Swine Diseases

Journal Title

J R Soc Interface

Conference Name

Journal ISSN

1742-5689
1742-5662

Volume Title

13

Publisher

The Royal Society
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/L001330/1)
European Commission (278976)
This work was supported by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (V.E.P., S.R., J.L.N.W. and B.T.G.) and the Bill & Melinda Gates Foundation (V.E.P. and B.T.G.). J.L.N.W. is also supported by the Alborada Trust, the European Union FP7 project ANTIGONE (contract no. 278976) and by Biotechnology and Biological Sciences Research Council sLOLA BB/L001330/1.